Quratis Inc. (KOSDAQ:348080)

-28.69% (1Y)

Market Cap	72.61B
Revenue	n/a
Net Income	n/a
Shares Out	73.86M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	964,971
Average Volume	590,804
Open	893.00
Previous Close	893.00
Day's Range	892.00 - 1,011.00
52-Week Range	516.00 - 2,095.00
Beta	-0.44
RSI	46.80
Earnings Date	n/a

About Quratis

Quratis Inc. engages in developing vaccines in South Korea. It is involved in developing QTP101, a vaccine for tuberculosis; dendritic cell-based cell therapy for indications, including cancer, autoimmune, and infectious diseases; and peptide nucleic acid-based antimicrobial agents. The company also offers drugs contract development and manufacturing services. Quratis Inc. was founded in 2016 and is based in Seoul, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 348080